NCT02351050View on ClinicalTrials.gov

Sonolysis in Risk Reduction of Symptomatic and Silent Brain Infarctions During Coronary Stenting

NACompletedINTERVENTIONAL
Enrollment

144

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

September 30, 2017

Study Completion Date

November 30, 2017

Conditions
Coronary Artery Disease
Interventions
DEVICE

Sonolysis

continual transcranial Doppler monitoring of middle cerebral artery

OTHER

Sham procedure

sham transcranial Doppler monitoring of middle cerebral artery

Trial Locations (1)

70852

University Hospital Nitra, Nitra

All Listed Sponsors
lead

University Hospital Ostrava

OTHER

NCT02351050 - Sonolysis in Risk Reduction of Symptomatic and Silent Brain Infarctions During Coronary Stenting | Biotech Hunter | Biotech Hunter